NEXENTIS TECHNOLOGIES INC. Equity Securities Fv Ni Current And Noncurrent
NEXENTIS TECHNOLOGIES INC. (NXTS) had Equity Securities Fv Ni Current And Noncurrent of $1.43 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Assets
us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent · last filed 2025-03-31
- 2024-09-30: Equity Securities Fv Ni Current And Noncurrent $1.43M.
- 2024-06-30: Equity Securities Fv Ni Current And Noncurrent $100.00.
- 2024-03-31: Equity Securities Fv Ni Current And Noncurrent $1.50K.
- 2023-12-31: Equity Securities Fv Ni Current And Noncurrent $1.00K; Equity Securities Fv Ni Current And Noncurrent as first filed $900.00.
| Period end | Equity Securities Fv Ni Current And Noncurrent | Equity Securities Fv Ni Current And Noncurrent as first filed |
|---|---|---|
| 2024-09-30 | $1.43M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $100.00 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.50K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.00K 10-K · filed 2025-03-31 | $900.00 10-K · filed 2024-04-01 |
| 2023-09-30 | $42.70K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $198.80K 10-Q · filed 2023-08-14 | |
| 2023-04-05 | $272.00K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |